BWF 2016 BWF vs Ratchanok Intanon

In July 2016 the Badminton World Federation (BWF) has reported an anti-doping rule violation against the Thai Athlete Ratchanok Intanon after her sample tested positive for the prohibited substance Triamcinolone.

After notification a provisional suspension was ordered and the Athlete accepted the test results.
The Athlete’s medical evidence together with the testimony from an expert witness estabilshed to the satisfaction of the Panel that the substance was administered in May 2016, before the competition as part of on‐going medical treatment of the athlete and that the route of administration of the substance was intra‐tendinous. The Panel concludes that for this mecical treatment no TUE was necessary.

Therefore the BWF Hearing Panel decides on 17 July 2016 that the Athlete did not commit an anti-doping rule violation.

show »
Type:
pdf

Parameters:

Doping classes
S9. Glucocorticosteroids
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Legal
Decisions International Federations
Date:
17 July 2016
Arbitrator
Chandran, P.S.M.
Graf-Baumann, Toni
Hansen, Rune Bård
Source
Badminton World Federation (BWF)
Country
Thailand
Language
English
ADRV
Adverse Analytical Finding
Document type
pdf
Health/Medical
Legitimate Medical Treatment
IF'S
Badminton (BWF) - Badminton World Federation
Legal Terms
Acquittal
Circumstantial evidence
No Fault or Negligence
Substances
Triamcinolone
Category
  • (Medical) Science
  • Doping classes
  • Education
  • History
  • Laboratories
  • Legal
  • Statistics
Publication period
Origin
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Document category
  • Document type
  • Health/Medical
  • IF'S
  • Laboratories/Analysis
  • Legal Terms
  • Organisations
  • Substances
  • Various
  • Version